Table 5.
Intervention process measures of care.
| Intervention | Usual Care | Difference (95% CI) | P | |
|---|---|---|---|---|
| Care manager contacts, median (range) | ||||
| 2-Months | 3 (0–8) | N/A | -- | -- |
| 4-Months | 5.5 (0–14) | N/A | -- | -- |
| 8-Months | 10 (0–28) | N/A | -- | -- |
| ≥ 3 Registry mentions of workbook use | ||||
| 2-Months | 65% (97/150) | N/A | -- | -- |
| 4-Months | 75% (113/150) | N/A | -- | -- |
| 8-Months | 85% (128/150) | N/A | -- | -- |
| Antidepressant Pharmacotherapy, self-reported* | ||||
| Baseline | 15% (22/150) | 9% (13/152) | 6% (−1–13) | 0.10 |
| 2-Months | 44% (54/122) | 26% (35/135) | 18% (7–30) | 0.002 |
| 4-Months | 42% (51/122) | 26% (35/134) | 16% (4–27) | 0.008 |
| 8-Months | 44% (55/126) | 31% (40/127) | 13% (1–24) | 0.05 |
| Mental health specialist visit, self-reported | ||||
| 2-Months | 3% (4/122) | 2% (3/135) | 1% (−3–5) | 0.60 |
| 4-Months | 4% (5/122) | 1% (2/134) | 3% (−1–7) | 0.20 |
| 8-Months | 4% (5/126) | 6% (7/127) | −2% (−7–4) | 0.56 |
*
Antidepressant pharmacotherapy includes selective serotonin reuptake inhibitors (SSRIs), selective serotonin norepinephrine reuptake inhibitors (SNRIs), bupropion, and mirtazapine